References (Supplied by CrossRef)
Cancer statistics, 2017
Siegel et al.
CA. Cancer J. Clin 2017
Advances in prostate cancer treatment
Trewartha et al.
Nat. Rev. Drug Discov 2013
Understanding heterogeneity of treatment effect in prostate cancer
Aly et al.
Curr. Opin. Oncol 2015
Designing the selenium and vitamin E Cancer Prevention Trial (SELECT)
Lippman et al.
J. Natl. Cancer Inst 2005
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Klein et al.
Long-term survival of participants in the prostate cancer prevention trial
Thompson et al.
N. Engl. J. Med 2013
Effect of dutasteride on the risk of prostate cancer
Andriole et al.
N. Engl. J. Med 2010
Prostate cancer prevention with 5-alpha reductase inhibitors: concepts and controversies
Liss et al.
Curr. Opin. Urol 2018
The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention
Theoret et al.
N. Engl. J. Med 2011
A census of amplified and overexpressed human cancer genes
Santarius et al.
Nat. Rev. Cancer 2010
Abnormal expression of MDM2 in prostate carcinoma
Leite et al.
Mod. Pathol 2001